These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31351802)

  • 1. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma.
    Uguen A; Talagas M; Costa S; Duigou S; Bouvier S; De Braekeleer M; Marcorelles P
    Diagn Pathol; 2015 Oct; 10():195. PubMed ID: 26503349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma.
    Ritter A; Tronnier M; Vaske B; Mitteldorf C
    Arch Dermatol Res; 2018 May; 310(4):329-342. PubMed ID: 29417221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas.
    Uguen A; Uguen M; Guibourg B; Talagas M; Marcorelles P; De Braekeleer M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):361-367. PubMed ID: 27490764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
    Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
    J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
    Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
    Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
    Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
    Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
    Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
    J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME immunohistochemistry of spitzoid neoplasms.
    Koh SS; Lau SK; Scapa JV; Cassarino DS
    J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.
    Kapur P; Selim MA; Roy LC; Yegappan M; Weinberg AG; Hoang MP
    Mod Pathol; 2005 Feb; 18(2):197-204. PubMed ID: 15467715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9p21 gene locus in Spitz nevi of older individuals: absence of cytogenetic and immunohistochemical findings associated with malignancy.
    Horst BA; Terrano D; Fang Y; Silvers DN; Busam KJ
    Hum Pathol; 2013 Dec; 44(12):2822-8. PubMed ID: 24134932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spitz Nevus and Other Spitzoid Tumors in Children -Part 1: Clinical, Histopathologic, and Immunohistochemical Features.
    Sainz-Gaspar L; Sánchez-Bernal J; Noguera-Morel L; Hernández-Martín A; Colmenero I; Torrelo A
    Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):7-19. PubMed ID: 31787210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment.
    Cho-Vega JH
    Mod Pathol; 2016 Jul; 29(7):656-70. PubMed ID: 27102343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma.
    Hilliard NJ; Krahl D; Sellheyer K
    J Cutan Pathol; 2009 Jul; 36(7):753-9. PubMed ID: 19519606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67.
    Milman T; Zhang Q; Ang S; Elder D; Ida CM; Salomao DR; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC
    Hum Pathol; 2020 Sep; 103():107-119. PubMed ID: 32707054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma.
    Oaxaca G; Billings SD; Ko JS
    J Cutan Pathol; 2020 Sep; 47(9):815-823. PubMed ID: 32330325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
    Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
    J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acral Spitz Nevi: A Clinicopathologic Study of 50 Cases With Immunohistochemical Analysis of P16 and P21 Expression.
    Wiedemeyer K; Guadagno A; Davey J; Brenn T
    Am J Surg Pathol; 2018 Jun; 42(6):821-827. PubMed ID: 29537991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.